文献
J-GLOBAL ID:202202210678098576
整理番号:22A0576118
虚弱表現型による心不全患者の遠隔医療の有効性:iCOR無作為化対照試験からの洞察【JST・京大機械翻訳】
Effectiveness of telemedicine in patients with heart failure according to frailty phenotypes: Insights from the iCOR randomised controlled trial
著者 (50件):
Yun Sergi
(Community Heart Failure Program, Departments of Cardiology and Internal Medicine, Bellvitge University Hospital, L’Hospitalet de Llobregat, Barcelona, Spain)
,
Yun Sergi
(Bio-Heart Cardiovascular Diseases Research Group, Bellvitge Biomedical Research Institute (IDIBELL), L’Hospitalet de Llobregat, Barcelona, Spain)
,
Yun Sergi
(Department of Internal Medicine, Bellvitge University Hospital, L’Hospitalet de Llobregat, Barcelona, Spain)
,
Enjuanes Cristina
(Community Heart Failure Program, Departments of Cardiology and Internal Medicine, Bellvitge University Hospital, L’Hospitalet de Llobregat, Barcelona, Spain)
,
Enjuanes Cristina
(Bio-Heart Cardiovascular Diseases Research Group, Bellvitge Biomedical Research Institute (IDIBELL), L’Hospitalet de Llobregat, Barcelona, Spain)
,
Enjuanes Cristina
(Department of Cardiology, Bellvitge University Hospital, L’Hospitalet de Llobregat, Barcelona, Spain)
,
Calero-Molina Esther
(Community Heart Failure Program, Departments of Cardiology and Internal Medicine, Bellvitge University Hospital, L’Hospitalet de Llobregat, Barcelona, Spain)
,
Calero-Molina Esther
(Bio-Heart Cardiovascular Diseases Research Group, Bellvitge Biomedical Research Institute (IDIBELL), L’Hospitalet de Llobregat, Barcelona, Spain)
,
Calero-Molina Esther
(Department of Cardiology, Bellvitge University Hospital, L’Hospitalet de Llobregat, Barcelona, Spain)
,
Hidalgo Encarnacion
(Community Heart Failure Program, Departments of Cardiology and Internal Medicine, Bellvitge University Hospital, L’Hospitalet de Llobregat, Barcelona, Spain)
,
Hidalgo Encarnacion
(Bio-Heart Cardiovascular Diseases Research Group, Bellvitge Biomedical Research Institute (IDIBELL), L’Hospitalet de Llobregat, Barcelona, Spain)
,
Hidalgo Encarnacion
(Department of Cardiology, Bellvitge University Hospital, L’Hospitalet de Llobregat, Barcelona, Spain)
,
Jose Nuria
(Community Heart Failure Program, Departments of Cardiology and Internal Medicine, Bellvitge University Hospital, L’Hospitalet de Llobregat, Barcelona, Spain)
,
Jose Nuria
(Bio-Heart Cardiovascular Diseases Research Group, Bellvitge Biomedical Research Institute (IDIBELL), L’Hospitalet de Llobregat, Barcelona, Spain)
,
Jose Nuria
(Department of Cardiology, Bellvitge University Hospital, L’Hospitalet de Llobregat, Barcelona, Spain)
,
Calvo Elena
(Bio-Heart Cardiovascular Diseases Research Group, Bellvitge Biomedical Research Institute (IDIBELL), L’Hospitalet de Llobregat, Barcelona, Spain)
,
Calvo Elena
(Department of Cardiology, Bellvitge University Hospital, L’Hospitalet de Llobregat, Barcelona, Spain)
,
Calvo Elena
(Faculty of medicine and Health Sciences, School of Nursing, University of Barcelona (UB), Barcelona, Spain)
,
Verdu-Rotellar Jose Maria
(Heart Diseases Biomedical Research Group, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain)
,
Verdu-Rotellar Jose Maria
(School of Medicine, Universitat Autonoma de Barcelona, Barcelona, Spain)
,
Verdu-Rotellar Jose Maria
(Jordi Gol Primary Care Research Institute, Catalan Institute of Heath, Barcelona, Spain)
,
Garcimartin Paloma
(Heart Diseases Biomedical Research Group, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain)
,
Garcimartin Paloma
(Outpatient Clinics, Hospital del Mar, Parc de Salut Mar, Barcelona, Spain)
,
Garcimartin Paloma
(Escuela Superior de Enfermeria del Mar, Parc de Salut Mar, Barcelona, Spain)
,
Chivite David
(Department of Internal Medicine, Bellvitge University Hospital, L’Hospitalet de Llobregat, Barcelona, Spain)
,
Chivite David
(Bellvitge Biomedical Research Institute (IDIBELL), L’Hospitalet de Llobregat, Barcelona, Spain)
,
Formiga Francesc
(Department of Internal Medicine, Bellvitge University Hospital, L’Hospitalet de Llobregat, Barcelona, Spain)
,
Formiga Francesc
(Bellvitge Biomedical Research Institute (IDIBELL), L’Hospitalet de Llobregat, Barcelona, Spain)
,
Jimenez-Marrero Santiago
(Community Heart Failure Program, Departments of Cardiology and Internal Medicine, Bellvitge University Hospital, L’Hospitalet de Llobregat, Barcelona, Spain)
,
Jimenez-Marrero Santiago
(Bio-Heart Cardiovascular Diseases Research Group, Bellvitge Biomedical Research Institute (IDIBELL), L’Hospitalet de Llobregat, Barcelona, Spain)
,
Jimenez-Marrero Santiago
(Department of Cardiology, Bellvitge University Hospital, L’Hospitalet de Llobregat, Barcelona, Spain)
,
Jimenez-Marrero Santiago
(Department of Cardiology, Cardio-Oncology Unit, Bellvitge University Hospital and Catalan Institute of Oncology, L’Hospitalet del Llobregat, Barcelona, Spain)
,
Garay Alberto
(Community Heart Failure Program, Departments of Cardiology and Internal Medicine, Bellvitge University Hospital, L’Hospitalet de Llobregat, Barcelona, Spain)
,
Garay Alberto
(Bio-Heart Cardiovascular Diseases Research Group, Bellvitge Biomedical Research Institute (IDIBELL), L’Hospitalet de Llobregat, Barcelona, Spain)
,
Garay Alberto
(Department of Cardiology, Bellvitge University Hospital, L’Hospitalet de Llobregat, Barcelona, Spain)
,
Garay Alberto
(Department of Cardiology, Cardio-Oncology Unit, Bellvitge University Hospital and Catalan Institute of Oncology, L’Hospitalet del Llobregat, Barcelona, Spain)
,
Alcoberro Lidia
(Community Heart Failure Program, Departments of Cardiology and Internal Medicine, Bellvitge University Hospital, L’Hospitalet de Llobregat, Barcelona, Spain)
,
Alcoberro Lidia
(Bio-Heart Cardiovascular Diseases Research Group, Bellvitge Biomedical Research Institute (IDIBELL), L’Hospitalet de Llobregat, Barcelona, Spain)
,
Alcoberro Lidia
(Department of Cardiology, Bellvitge University Hospital, L’Hospitalet de Llobregat, Barcelona, Spain)
,
Moliner Pedro
(Community Heart Failure Program, Departments of Cardiology and Internal Medicine, Bellvitge University Hospital, L’Hospitalet de Llobregat, Barcelona, Spain)
,
Moliner Pedro
(Bio-Heart Cardiovascular Diseases Research Group, Bellvitge Biomedical Research Institute (IDIBELL), L’Hospitalet de Llobregat, Barcelona, Spain)
,
Moliner Pedro
(Department of Cardiology, Bellvitge University Hospital, L’Hospitalet de Llobregat, Barcelona, Spain)
,
Moliner Pedro
(Department of Cardiology, Cardio-Oncology Unit, Bellvitge University Hospital and Catalan Institute of Oncology, L’Hospitalet del Llobregat, Barcelona, Spain)
,
Corbella Xavier
(Department of Internal Medicine, Bellvitge University Hospital, L’Hospitalet de Llobregat, Barcelona, Spain)
,
Corbella Xavier
(Bellvitge Biomedical Research Institute (IDIBELL), L’Hospitalet de Llobregat, Barcelona, Spain)
,
Corbella Xavier
(Hestia Chair in Integrated Health and Social Care, School of Medicine, Universitat Internacional de Catalunya, Barcelona, Spain)
,
Comin-Colet Josep
(Community Heart Failure Program, Departments of Cardiology and Internal Medicine, Bellvitge University Hospital, L’Hospitalet de Llobregat, Barcelona, Spain)
,
Comin-Colet Josep
(Bio-Heart Cardiovascular Diseases Research Group, Bellvitge Biomedical Research Institute (IDIBELL), L’Hospitalet de Llobregat, Barcelona, Spain)
,
Comin-Colet Josep
(Department of Cardiology, Bellvitge University Hospital, L’Hospitalet de Llobregat, Barcelona, Spain)
,
Comin-Colet Josep
(Department of Clinical Sciences, School of Medicine, University of Barcelona (UB), Barcelona, Spain)
資料名:
European Journal of Internal Medicine
(European Journal of Internal Medicine)
巻:
96
ページ:
49-59
発行年:
2022年
JST資料番号:
W3247A
ISSN:
0953-6205
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)